SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-023076
Filing Date
2023-05-05
Accepted
2023-05-05 07:01:42
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-05

Document Format Files

Seq Description Document Type Size
1 ARS ny20008400x5_ars.pdf ARS 514939
  Complete submission text file 0001140361-23-023076.txt   710834
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-11460 | Film No.: 23891178
SIC: 2834 Pharmaceutical Preparations